Company Profile
Updated: 17-SEP-09Archemix Corp.
Private Company, Headquarters Location
300 3rd St., Cambridge, MA 02139-1103, United States
(617)621-7700, (617)621-9300 fax, http://www.archemix.com
Primary SIC: Biological Products Except Diagnostic, Primary NAICS: Biological Product (except Diagnostic) Manufacturing
Description: Manufacturing: A biopharmaceutical company committed to the discovery and development of aptamer-bases therapeutics.
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
Ophthotech Gets $30M Series B for Trials of Lucentis Add-Ons.
BIOWORLD Today; 12/15/2009; 1346 words; Staff Writer Ophthotech Corp. is expected to announce on Tuesday...BioPharma Inc. (now Facet Biotech Corp.) and Biogen Idec Inc. The two are...complement factor inhibitor licensed from Archemix Corp. That drug is in a Phase I Lucentis...
Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities.
PR Newswire; 12/2/2009; 2340 words; ...Technologies 15 6. CORPORATE DEVELOPMENTS 15 Affymetrix Acquires USB Corp 15 Roche Acquires Ventana Medical Systems 15 Bruker BioSciences...16 Implant Sciences to Acquire Ion Metrics 17 NascaCell and Archemix Expand Partnership for Aptamer-Based Drugs 17 DiscoveRx and...
$37M Addition Brings Archemix Series A Financing To $51.75M.
BIOWORLD Today; 11/4/2009; 736 words; Staff Writer Archemix Corp. completed a Series A round that began...will be used, said Martin Stanton, Archemix president and a company founder...November 2001, Cambridge, Mass.-based Archemix licensed the aptamer technology from...
Appointments And Advancements.
BIOWORLD Today; 11/4/2009; 1087 words; ...Susan Wyant. Advanced Viral Research Corp., of Yonkers, N.Y., added...president and chief information officer. Archemix Corp., of Cambridge, Mass., appointed...chief operating officer. Connetics Corp., of Palo Alto, Calif., appointed...
Other News To Note.
BIOWORLD Today; 11/3/2009; 2473 words; ...expects to report results in late 2005 or early 2006. o Archemix Corp., of Cambridge, Mass., received an undisclosed milestone...11 cents to close at 56 cents. o Generex Biotechnology Corp., of Toronto, said its subsidiary, Antigen Express...
Recent News Articles
- Archemix Corp.-Company Report.
M2 Presswire - February 08, 2009 - FierceBiotech Names Archemix Corp. as One of the "Fierce 15" Biotech Companies of 2007.
Business Wire - June 06, 2007 - Nuvelo and Archemix expand aptamer accord.(research agreements between Archemix Corp and Nuvelo Inc)(Brief article)
Pharma Marketletter - August 14, 2006 - Archemix Corp. Strengthens its Board of Directors Adding Alnylam President and CEO, John Maraganore, Ph.D.
PR Newswire - May 31, 2006
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning